Asia Pacific Arthritic Therapeutic Market Size, Share & Trends Analysis Report By Application (Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others), By Product Type, By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Arthritic Therapeutic Market would witness market growth of 6.0% CAGR during the forecast period (2023-2030).

The China market dominated the Asia Pacific Arthritic Therapeutic Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $7,820.8 Million by 2030. The Japan market is registering a CAGR of 5.3% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.7% during (2023 - 2030).

Healthcare providers are more likely to adopt therapies supported by robust evidence of efficacy, safety, and long-term outcomes, while patients are more inclined to adhere to treatments that offer tangible benefits with minimal adverse effects. For instance, as per Invest India, India’s healthcare industry is expanding at a rapid rate due to its expanding coverage, services, and rising expenditures by both public and private players.

Biologic agents, such as tumor necrosis factor (TNF) inhibitors, interleukin inhibitors, and Janus kinase (JAK) inhibitors, target specific inflammatory pathways implicated in autoimmune forms of arthritis, like psoriatic arthritis, ankylosing spondylitis, and rheumatoid arthritis. These medications help suppress the immune system, reduce joint damage, and prevent structural deformities, thereby preserving joint function and improving long-term outcomes.

Telemedicine and digital health technologies enhance access to healthcare services for individuals residing in underserved or remote parts of India by overcoming geographical barriers. Digital health tools, encompassing wearable devices, mobile applications, and remote monitoring platforms, provide individuals with arthritis in India with enhanced capabilities to administer treatment remotely, trace disease activity, and monitor symptoms more efficiently. Therefore, due to the above-mentioned factors, the market will grow significantly in this region.

Free Valuable Insights: The Global Arthritic Therapeutic Market is Predict to reach $ 112.6 Billion by 2030, at a CAGR of 5.1%

Based on Application, the market is segmented into Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis, Ankylosing Spondylitis and Others. Based on Product Type, the market is segmented into Non-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modified Anti-rheumatoid Drugs (DMARDs), Biologics, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• AbbVie, Inc.
• Pfizer, Inc.
• Amgen, Inc.
• Novartis AG
• F.Hoffmann-La Roche Ltd.
• Viatris, Inc.
• Bausch Health Companies, Inc.
• Sanofi S.A.
• Merck & Co., Inc.
• Bristol-Myers Squibb Company

Asia Pacific Arthritic Therapeutic Market Report Segmentation

By Application

• Rheumatoid Arthritis
• Psoriatic Arthritis
• Osteoarthritis
• Ankylosing Spondylitis
• Others

By Product Type

• Non-steroidal Anti-inflammatory Drugs (NSAIDs)
• Disease Modified Anti-rheumatoid Drugs (DMARDs)
• Biologics
• Others

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Arthritic Therapeutic Market, by Application
1.4.2 Asia Pacific Arthritic Therapeutic Market, by Product Type
1.4.3 Asia Pacific Arthritic Therapeutic Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in the Arthritic Therapeutic Market

Chapter 5. Asia Pacific Arthritic Therapeutic Market, by Application
5.1 Asia Pacific Rheumatoid Arthritis Market, by Country
5.2 Asia Pacific Psoriatic Arthritis Market, by Country
5.3 Asia Pacific Osteoarthritis Market, by Country
5.4 Asia Pacific Ankylosing Spondylitis Market, by Country
5.5 Asia Pacific Others Market, by Country

Chapter 6. Asia Pacific Arthritic Therapeutic Market, by Product Type
6.1 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country
6.2 Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country
6.3 Asia Pacific Biologics Market, by Country
6.4 Asia Pacific Others Market, by Country

Chapter 7. Asia Pacific Arthritic Therapeutic Market, by Country
7.1 China Arthritic Therapeutic Market
7.1.1 China Arthritic Therapeutic Market, by Application
7.1.2 China Arthritic Therapeutic Market, by Product Type
7.2 Japan Arthritic Therapeutic Market
7.2.1 Japan Arthritic Therapeutic Market, by Application
7.2.2 Japan Arthritic Therapeutic Market, by Product Type
7.3 India Arthritic Therapeutic Market
7.3.1 India Arthritic Therapeutic Market, by Application
7.3.2 India Arthritic Therapeutic Market, by Product Type
7.4 South Korea Arthritic Therapeutic Market
7.4.1 South Korea Arthritic Therapeutic Market, by Application
7.4.2 South Korea Arthritic Therapeutic Market, by Product Type
7.5 Singapore Arthritic Therapeutic Market
7.5.1 Singapore Arthritic Therapeutic Market, by Application
7.5.2 Singapore Arthritic Therapeutic Market, by Product Type
7.6 Malaysia Arthritic Therapeutic Market
7.6.1 Malaysia Arthritic Therapeutic Market, by Application
7.6.2 Malaysia Arthritic Therapeutic Market, by Product Type
7.7 Rest of Asia Pacific Arthritic Therapeutic Market
7.7.1 Rest of Asia Pacific Arthritic Therapeutic Market, by Application
7.7.2 Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type

Chapter 8. Company Profiles
8.1 AbbVie, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Pfizer, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Amgen, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 Novartis AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Trials and Approvals:
8.4.6 SWOT Analysis
8.5 F. Hoffmann-La Roche Ltd.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 SWOT Analysis
8.6 Viatris, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Trials and Approvals:
8.6.6 SWOT Analysis
8.7 Bausch Health Companies, Inc
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.6 SWOT Analysis
8.9 Merck & Co., Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.6 SWOT Analysis
8.10. Bristol-Myers Squibb Company
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis

TABLE 1 Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Rheumatoid Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Rheumatoid Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Psoriatic Arthritis Market, by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Psoriatic Arthritis Market, by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Osteoarthritis Market, by Country, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Osteoarthritis Market, by Country, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Ankylosing Spondylitis Market, by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Ankylosing Spondylitis Market, by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 17 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific Non-steroidal Anti-inflammatory Drugs (NSAIDs) Market, by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Disease Modified Anti-rheumatoid Drugs (DMARDs) Market, by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Biologics Market, by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Biologics Market, by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 Asia Pacific Arthritic Therapeutic Market, by Country, 2019 - 2022, USD Million
TABLE 26 Asia Pacific Arthritic Therapeutic Market, by Country, 2023 - 2030, USD Million
TABLE 27 China Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 28 China Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 29 China Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 30 China Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 31 China Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 32 China Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 33 Japan Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 34 Japan Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 35 Japan Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 36 Japan Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 37 Japan Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 38 Japan Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 39 India Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 40 India Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 41 India Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 42 India Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 43 India Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 44 India Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 45 South Korea Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 46 South Korea Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 47 South Korea Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 48 South Korea Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 49 South Korea Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 50 South Korea Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 51 Singapore Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 52 Singapore Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 53 Singapore Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 54 Singapore Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 55 Singapore Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 56 Singapore Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 57 Malaysia Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 58 Malaysia Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 59 Malaysia Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 60 Malaysia Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 61 Malaysia Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 62 Malaysia Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 63 Rest of Asia Pacific Arthritic Therapeutic Market, 2019 - 2022, USD Million
TABLE 64 Rest of Asia Pacific Arthritic Therapeutic Market, 2023 - 2030, USD Million
TABLE 65 Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2022, USD Million
TABLE 66 Rest of Asia Pacific Arthritic Therapeutic Market, by Application, 2023 - 2030, USD Million
TABLE 67 Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2022, USD Million
TABLE 68 Rest of Asia Pacific Arthritic Therapeutic Market, by Product Type, 2023 - 2030, USD Million
TABLE 69 Key information – AbbVie, Inc.
TABLE 70 Key Information – Pfizer, Inc.
TABLE 71 Key Information – Amgen, Inc.
TABLE 72 Key Information – Novartis AG
TABLE 73 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 74 Key Information – Viatris, Inc.
TABLE 75 key information – Bausch Health Companies, Inc.
TABLE 76 Key Information – Sanofi S.A.
TABLE 77 Key Information - Merck & Co., Inc.
TABLE 78 Key Information – Bristol-Myers Squibb Company

List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Arthritic Therapeutic Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Arthritic Therapeutic Market
FIG 4 Porter’s Five Forces Analysis - Arthritic Therapeutic Market
FIG 5 Asia Pacific Arthritic Therapeutic Market share, by Application, 2022
FIG 6 Asia Pacific Arthritic Therapeutic Market share, by Application, 2030
FIG 7 Asia Pacific Arthritic Therapeutic Market, by Application, 2019 - 2030, USD Million
FIG 8 Asia Pacific Arthritic Therapeutic Market share, by Product Type, 2022
FIG 9 Asia Pacific Arthritic Therapeutic Market share, by Product Type, 2030
FIG 10 Asia Pacific Arthritic Therapeutic Market, by Product Type, 2019 - 2030, USD Million
FIG 11 Asia Pacific Arthritic Therapeutic Market share, by Country, 2022
FIG 12 Asia Pacific Arthritic Therapeutic Market share, by Country, 2030
FIG 13 Asia Pacific Arthritic Therapeutic Market, by Country, 2019 - 2030, USD Million
FIG 14 Swot Analysis: AbbVie, Inc.
FIG 15 SWOT Analysis: Pfizer, Inc.
FIG 16 Swot Analysis: Amgen, Inc.
FIG 17 SWOT Analysis: Novartis AG
FIG 18 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 19 SWOT Analysis: Viatris, Inc.
FIG 20 SWOT Analysis: Bausch Health Companies, Inc.
FIG 21 Swot Analysis: Sanofi S.A.
FIG 22 SWOT Analysis: Merck & Co., Inc.
FIG 23 SWOT Analysis: Bristol-Myers Squibb Company